MetaCap

BrightSpring Health Services Tangible Equity Unit (BTSGU) vs Certara (CERT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

BrightSpring Health Services Tangible Equity Unit (BTSGU) has outperformed Certara (CERT) over the past year, gaining 102.8% versus a loss of 30.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BTSGU+102.81%CERT-28.31%
+158%+41%-76%
Oct 7, 20251 yearOct 6, 2026
BTSGU+338.56%CERT-46.09%
+455%+178%-98%
Jan 22, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BTSGU versus CERT key metrics
MetricBTSGUCERT
Share price$196.24$8.96
Market cap—$1.37B
1-day change0.00%-3.34%
YTD return+56.37%+1.70%
1-year return+102.81%-30.70%
5-year return—-76.32%
Forward P/E—23.04
EPS (TTM)—$-0.14
Dividend yield1.71%0.00%
Annual dividend$0.00$0.00
52-week high$255.51$13.12
52-week low$96.92$4.45
Distance from 52-week high-23.20%-31.71%
Analyst consensus—buy
Avg. price target upside—-3.79%
Average volume19.14K3.07M
Shares outstanding—152.54M
Employees23,5001,515
SectorHealth CareTechnology
IndustryMedical/Nursing ServicesComputer Software: Prepackaged Software

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BTSGU has outperformed CERT by 133.5 percentage points over the past year.
  • BrightSpring Health Services Tangible Equity Unit offers a meaningfully higher dividend yield (1.71% vs 0.00%).
  • The two companies sit in different sectors: BrightSpring Health Services Tangible Equity Unit in Health Care and Certara in Technology.

About BrightSpring Health Services Tangible Equity Unit

BTSGU stock →

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States.

Health Care · Medical/Nursing Services · 23,500 employees

About Certara

CERT stock →

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.

Technology · Computer Software: Prepackaged Software · 1,515 employees

BTSGU vs CERT FAQ

Which stock has performed better over the past year, BTSGU or CERT?

BTSGU returned +102.81% over the past 12 months, compared with -30.70% for CERT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, BrightSpring Health Services Tangible Equity Unit or Certara?

BrightSpring Health Services Tangible Equity Unit pays a dividend yielding 1.71%, while Certara does not currently pay a regular dividend.

Are BrightSpring Health Services Tangible Equity Unit and Certara in the same industry?

No. BrightSpring Health Services Tangible Equity Unit is in the Health Care sector, while Certara is in Technology.

More comparisons